Previous 10 | Next 10 |
Image source: The Motley Fool. Icon PLC (NASDAQ: ICLR) Q1 2021 Earnings Call Apr 30, 2021 , 10:00 p.m. ET Operator Continue reading For further details see: Icon PLC (ICLR) Q1 2021 Earnings Call Transcript
The following slide deck was published by ICON Public Limited Company in conjunction with their 2021 Q1 earnings call. For further details see: ICON Public Limited Company 2021 Q1 - Results - Earnings Call Presentation
Icon (ICLR): Q1 Non-GAAP EPS of $2.06 beats by $0.09; GAAP EPS of $1.82 misses by $0.14.Revenue of $858.2M (+20.0% Y/Y) beats by $68.83M.Standalone full year 2021 revenue guidance increased from a range of $3,200 - $3,300 million to a range of $3,400 - $3,500 million, representing a year over...
Highlights Record net business wins in the quarter of $1,100 million, an increase of 27% year on year; a net book to bill of 1.28. Record closing backlog of $10 billion, an increase of 14.0% year on year. Quarter 1 reported revenue of $858.2 million representin...
Solid biopharma demand, rising diagnostic trends, and the economic recovery will support a ‘healthy’ Q1 revenue growth argues UBS analyst Dan Brennan and the team in a Q1 2021 preview written on the sector of life sciences & diagnostic tools.The firm picks IQVIA Holdings ([[...
An influx of news into healthcare's contract research organization sector is calling for a re-rating, Baird says in looking at its preferred picks headed into Q1 earnings. First came an activist stake in Laboratory Corp. of America (LH) to press for strategic alternatives. That was followed b...
Merger activity increased last week with six new deals announced. $50 billion worth of deals announced in a single week. Thermo Fisher Scientific to acquire PPD Inc. For further details see: Merger Arbitrage Mondays - Microsoft's Acquisition Of Nuance Offers A 5% Spread ...
Icon plc (ICLR) said it won HSR approval for its planned purchase of PRA Health (PRAH).Icon confirmed winning regulatory approval for the PRA deal in an email to Seeking Alpha. The HSR deadline expired for the deal expired yesterday.Earlier today Icon peer PPD (PPD) agreed to a sale of the co...
Syneos Health (SYNH) rose 5.2% following Thermo's Fisher (TMO) planned acquisition of PPD Inc. (PPD)Syneos Health is a per of PPD and in May Reuters reported that the contract research organization was exploring a sale.Other CRO Charles River Labs (CRL) rose 2.5%, while La...
ICON PLC is a Contract Research Organization that generated revenues of $2.8bn in FY20, and whose share price is +173% over a five-year period. Having potentially reached its rapid growth ceiling, the company has taken the decision to acquire its closest-matched sector rival PRA Healt...
News, Short Squeeze, Breakout and More Instantly...
Highlights Net business wins in the quarter of $2,579 million, an increase of 6.6% on quarter two 2023. Reflects a net book to bill in the quarter of 1.22, and a trailing twelve month net book to bill of 1.24. Closing backlog of $23.8 billion, an increase of 2.0% on quarter one 20...
ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organization, today announced that all resolutions at the Annual General Meeting of the company (AGM) held on July 23, 2024 were duly passed by shareholders. ICON also confirmed that following the conclus...
ICON plc , (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the first half of 2024 with a number of leading business and industry awards recognising the company’s leadership position in the clinical research industry, in addi...